تصفح Pharmacy Research حسب المؤلف "Ademi, Zanfina"
-
Cost-Effectiveness of Empagliflozin and Metformin Combination Versus Standard Care as First-Line Therapy in Patients With Type 2 Diabetes Mellitus
Dina, Abushanab; Liew, Danny; Marquina, Clara; Al-Badriyeh, Daoud; Ademi, Zanfina ( Elsevier , 2022 , Article)ObjectiveSodium-glucose cotransporter 2 inhibitors have been shown to reduce cardiovascular events but are currently not used as the first-line therapy. This study was conducted to evaluate the cost-effectiveness of ... -
First-line Treatment with Empagliflozin and Metformin Combination Versus Standard Care for Patients with Type 2 Diabetes Mellitus and Cardiovascular Disease in Qatar. A Cost-Effectiveness Analysis
Abushanab, Dina; Al-Badriyeh, Daoud; Liew, Danny; Ademi, Zanfina ( Elsevier , 2022 , Article)Sodium-glucose cotransporter 2 (SGLT2) inhibitors have shown to reduce cardiovascular events and mortality in patients with type 2 diabetes mellitus (T2DM), but they are currently not used as first-line therapy in clinical ... -
Projecting the Health and Economic Burden of Cardiovascular Disease Among People with Type 2 Diabetes, 2022–2031
Abushanab, Dina; Marquina, Clara; Morton, Jedidiah I.; Al-Badriyeh, Daoud; Lloyd, Melanie; Magliano, Dianna J.; Liew, Danny; Ademi, Zanfina... more authors ... less authors ( Springer Nature , 2023 , Article)Objective: The aim was to project the health and economic outcomes of cardiovascular disease (CVD) among people with type 2 diabetes from Australian public healthcare and societal perspectives over the next decade. Methods: ... -
Societal health and economic burden of cardiovascular diseases in the population with type 2 diabetes in Qatar. A 10-year forecasting model
Abushanab, Dina; Al-Badriyeh, Daoud; Marquina, Clara; Liew, Danny; Al-Zaidan, Manal; Ghaith Al-Kuwari, Mohammed; Abdulmajeed, Jazeel; Ademi, Zanfina... more authors ... less authors ( Wiley-Blackwell , 2023 , Article)Aims: To predict the future health and economic burden of cardiovascular disease (CVD) in type 2 diabetes (T2D) in Qatar. Materials and Methods: A dynamic multistate model was designed to simulate the progression of fatal ... -
A Systematic Review of Cost-Effectiveness of Non-Statin Lipid-Lowering Drugs for Primary and Secondary Prevention of Cardiovascular Disease in Patients with Type 2 Diabetes Mellitus
Dina, Abushanab; Al-Badriyeh, Daoud; Marquina, Clara; Bailey, Cate; Jaam, Myriam; Liew, Danny; Ademi, Zanfina... more authors ... less authors ( Elsevier , 2022 , Article)Although studies of nonstatin lipid-lowering therapies have demonstrated cardiovascular benefits; whether these benefits provide good value has not been evaluated in type 2 diabetes mellitus patients. A systematic review ...